Role of Faecalibacterium prausnitzii in Crohn's Disease: friend, foe, or does not really matter?

about

Role of Faecalibacterium prausnitzii in Crohn's Disease: friend, foe, or does not really matter?

Item

http://www.wikidata.org/entity/Q53542322

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Role of Faecalibacterium praus ...... oe, or does not really matter?

@en

Role of Faecalibacterium praus ...... oe, or does not really matter?

@nl

type

Item

label

Role of Faecalibacterium praus ...... oe, or does not really matter?

@en

Role of Faecalibacterium praus ...... oe, or does not really matter?

@nl

prefLabel

Role of Faecalibacterium praus ...... oe, or does not really matter?

@en

Role of Faecalibacterium praus ...... oe, or does not really matter?

@nl

P1476

Role of Faecalibacterium praus ...... oe, or does not really matter?

@en

P2093

Konstantinos Gerasimidis

http://www.w3.org/2001/XMLSchema#string

Laura Hanske

http://www.w3.org/2001/XMLSchema#string

Paraic McGrogan

http://www.w3.org/2001/XMLSchema#string

Richard Hansen

http://www.w3.org/2001/XMLSchema#string

Richard Russell

http://www.w3.org/2001/XMLSchema#string

P2860

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

A microbial symbiosis factor prevents intestinal inflammatory disease

Enterotoxigenic bacteroides fragilis: a potential instigator of colitis.

Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease.

Probiotics for the treatment of inflammatory bowel disease.

Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition.

Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis.

Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.

P304

E18-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000000079

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24859302

http://www.w3.org/2001/XMLSchema#string